Nomura Holdings Inc Arcutis Biotherapeutics, Inc. Call Options Transaction History

Nomura Holdings Inc

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$13.96 - $20.4 $368,544 - $538,560	-26,400 Reduced 44.0%	33,600 $492,000
Q3 2022 Nov 15, 2022	SELL	$17.85 - $26.95 $433,755 - $654,885	-24,300 Reduced 28.83%	60,000 $1.15 Million
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $1.38 Million - $1.87 Million	84,300 New	84,300 $1.83 Million

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.